BAYER BAYER 200 (Nexavar 200 mg)

Generic Name: sorafenib

Pill imprint BAYER BAYER 200 has been identified as Nexavar 200 mg.

Nexavar is used in the treatment of hepatocellular carcinoma; renal cell carcinoma; hepatic tumor; thyroid cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Nexavar 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for BAYER BAYER 200 (Nexavar 200 mg)

Nexavar 200 mg BAYER BAYER 200
Nexavar
Generic Name:
sorafenib
Imprint:
BAYER BAYER
200
Strength:
200 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bayer Healthcare Pharmaceuticals

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)